Partners

PATHs Program

Annual Meetings | PATHs Partners | Registry | Registry Forms | Registry Archive

Sixth Annual Meeting

Agenda | Objectives | Program | Participating Organizations

Agenda

CERTs 6th Annual Partnerships to Advance Therapeutics (PATHs) Meeting

The Future of Quality and Safety: Unique Challenges for Therapeutics

Tuesday, March 13, 2007
L'Enfant Plaza Hotel, Washington, DC

Objectives

To provide a forum for leaders of national organizations to:

• Identify potential activities the CERTs and the private sector could undertake to complement the government's effort to improve knowledge about the safe use of therapeutics;
• Identify lessons learned from MMA programs that may have application for future quality and safety initiatives; and
• Learn about initiatives of the CERTs and other organizations aimed at improving the safe and appropriate use of medications.

To Top

Program

9:00 Welcome and Opening Comments

9:15 Introductions

• Each participant will have a minute for introduction: name, organization, and a brief description of an initiative to improve health for which their organization is seeking partners.

10:00 Keynote Presentations

• AHRQ Perspective: Evidence to support patient and provider decision-making
  Jean Slutsky, PA, MSPH, Director, Center for Outcomes and Evidence

• FDA Perspective: How do we do a better job of learning about the safe use of therapeutics?
  Steven Galson, MD, MPH, Director, Center for Drug Evaluation and Research

• CMS Perspective: What have we learned from the MMA about how to improve the quality of therapeutics use?
  Jeffrey Kelman, MD, Medical Director, Center for Beneficiary Choices

11:00 Break

11:15 Concurrent Sessions:

• Session I: How do we do a better job of learning about the safe use of therapeutics?
  Moderator: Raymond Woosley, MD, PhD

• An investigator's view of the CDC's vaccine safety efforts
  Richard Platt, MD, MS, Professor and Chair, Department of Ambulatory Care, Harvard Medical School

• Therapeutics Safety for Veterans: Interface between Research and Practice
  Seth Eisen, MD, MSc, Director, Health Services Research & Development Service, Department of Veterans Affairs

• Risk Communication to Physicians about Drugs
  Joseph Cranston, PhD, Director, Division of Science, Research and Technology, American Medical Association

Discussion: What activities could CERTs and the private sector undertake to complement the government's effort to improve knowledge about the safe use of therapeutics?

• Session II: What have we learned from the MMA?
  Moderator: Kenneth Saag, MD, MSc

• Experience of Community Pharmacies with Medication Therapy Management
  William Doucette, PhD, Director, Center for Improving Medication Use in the Community, University of Iowa

• Development and Use of Medication Quality of Care MeasuresMbr /> James Grant, MA, Project Manager, Physician Practice-Pharmacy Quality Improvement Organization Support Center

• Prescription Drug Care Coordination Program
  Patrick Irvine, MD, Medical Director, Prescription Drug Care Coordination Program, UMWA Health & Retirement Funds

Discussion: What are the lessons learned from these MMA programs that may have application for future quality and safety initiatives?

1:15 Break

1:30 Reports from Concurrent Sessions

2:00 Keynote Presentation: A Business Perspective on Some of the Critical Therapeutics Issues Facing the U.S. Today

• Anthony C. Wisniewski
  Executive Director, Health Policy, U.S. Chamber of Commerce

2:20 Closing Comments

2:30 Adjourn

To Top

Participating Organizations

American Association of Retired Persons
American Autoimmune Related Diseases Association
Academy of Managed Care Pharmacy
Academy of Pharmaceutical Physicians and Investigators
Agency for Healthcare Research and Quality
American Academy of Child and Adolescent Psychiatry
American Academy of Pediatrics
American Association of Colleges of Pharmacy
American College of Cardiology
American College of Clinical Pharmacology
American College of Clinical Pharmacy
American College of Preventative Medicine
American Health Quality Association
American Heart Association
American Medical Association
American Society of Health-System Pharmacists Research and Education Foundation
Arthritis Foundation
Caremark
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Consumers Union
Department of Veterans Affairs
Eli Lilly and Company
FMQAI
Food and Drug Administration
i3 Drug Safety
International Society for Pharmacoepidemiology
Johnson & Johnson
Merck & Co., Inc.
National Consumers League
National Council on Patient Information and Education
National Minority Quality Forum
National Pharmaceutical Council
National Quality Forum
PhRMA
Society for Women's Health Research
United Mine Workers of American Health and Retirement Funds
United States Pharmacopeia
US Chamber of Commerce